St. Charles, MO – April 24, 2024 - In the dynamic landscape of pharmaceuticals, every innovation that accelerates the drug development process is to be celebrated. Today, we announce a groundbreaking partnership between Natoli Engineering, the renowned leader in tablet compression tooling, and TaBlitz, a pioneering force in drug development technology. Together, these industry giants are poised to revolutionize the pharmaceutical landscape by expediting drug development and enhancing efficiency like never before.
Natoli Engineering's expertise in tablet compression tooling is unmatched, with a legacy of over 50 years of excellence. Their precision-engineered tools are integral to the tablet manufacturing process, ensuring quality, reliability, and efficiency at every stage. With a global footprint and a reputation for innovation, Natoli Engineering has consistently been at the forefront of advancements in pharmaceutical manufacturing.
“The partnership between Natoli Engineering and TaBlitz underscores a commitment to excellence, collaboration, and continuous improvement within the pharmaceutical industry. By providing seamless integration between formulation development and manufacturing processes, the partnership will enable pharmaceutical companies to collaborate more effectively, accelerate innovation, and deliver medications that meet the highest standards of quality and safety,” said Dale Natoli, President of Natoli Engineering.
TaBlitz brings innovative technology to the table, specializing in software solutions that streamline the drug development process. Their proprietary platform leverages artificial intelligence, machine learning, and data analytics to optimize formulation design, process development, and manufacturing strategies. By harnessing the power of data-driven insights, TaBlitz empowers pharmaceutical companies to make informed decisions swiftly, reducing time to market and minimizing development costs.
"We are excited to join forces with Natoli Engineering to drive innovation and efficiency in the pharmaceutical industry," said Michael Ruch, Co-Founder at TaBlitz. "Together, we will empower pharmaceutical companies to bring medications to market faster, while upholding the highest standards of quality and compliance.”
The synergy between Natoli Engineering and TaBlitz is a game-changer for the pharmaceutical industry. First and foremost, it means efficiency. By streamlining the formulation development process, optimizing manufacturing parameters, and minimizing scale-up challenges, Natoli and TaBlitz enable pharmaceutical companies to bring medications to market faster than ever before. Moreover, the partnership fosters collaboration and knowledge-sharing within the industry. By providing seamless integration between formulation development and manufacturing processes, Natoli and TaBlitz empower pharmaceutical companies to collaborate more effectively across departments and geographical boundaries. This collaboration not only accelerates the pace of innovation but also fosters a culture of continuous improvement and excellence within the industry.
For more information about Natoli Engineering and TaBlitz, visit Natoli.com and TaBlitz.us
About Natoli Engineering:
Natoli Engineering is the global leader in tablet compression tooling and encapsulation, offering a comprehensive range of products and services to pharmaceutical, nutraceutical, and confectionery industries worldwide. With over 50 years of experience and a reputation for innovation and excellence, Natoli Engineering is committed to helping customers optimize tablet manufacturing processes and achieve their production goals.
About TaBlitz:
TaBlitz Inc., is a groundbreaking platform, a first-of-its-kind AI-powered 3D tablet design software. We house deep learning models that guide and suggest our customers to more effective designs from the infant phases of the drug development process. Minimizing iterations, expediting development, and streamlining knowledge transfer between internal departments and external vendors. Providing critical data and rapid analysis of designs, TaBlitz is poised to solidify its role as the cornerstone of transformative drug development practices.
Comments